Enveric Biosciences, Inc. — Director's Dealing 2021

Feb 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enveric Biosciences, Inc. (ENVB)
CIK: 0000890821
Period of Report: 2021-02-15

Reporting Person: Mayer Solomon (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-15	Common Stock	A	15957	—	Acquired	15957	Direct

Footnotes

F1: Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan (the "Plan"). Such shares shall vest in full on December 30, 2021, or the one-year anniversary of the date on which the reporting person commenced providing services to the issuer as a member of its board of directors, subject to the terms and conditions of the Plan and the reporting person's restricted stock award agreement.